سعر Xefo 8 mg vial i.m./i.v. 2026

دواعي استعمال Xefo 8

Short-term relief of acute mild to moderate pain.الفئة: AdultsHealth Products Regulatory Authority (HPRA), Ireland

Short-term relief of acute mild to moderate pain.Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland

الآثار الجانبيةSide effects

About 20% of patients may experience adverse reactions; most frequent are nausea, dyspepsia, indigestion, abdominal pain, vomiting and diarrhoea (generally under 10%).نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA), Ireland

About 20% of patients may experience adverse reactions; most frequent are nausea, dyspepsia, indigestion, abdominal pain, vomiting and diarrhoea (generally under 10%).International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

موانع الاستعمالContraindications

Hypersensitivity to lornoxicam or excipients; thrombocytopenia; hypersensitivity (asthma, rhinitis, angioedema, urticaria) to other NSAIDs including aspirin; severe heart failure; GI, cerebrovascular or other bleeding disorders; history of NSAID-related GI bleeding/perforation; active or recurrent peptic ulcer; severe hepatic impairment; severe renal impairment (serum creatinine >700 µmol/L); third trimester of pregnancy.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA), Ireland

Hypersensitivity to lornoxicam or excipients; thrombocytopenia; hypersensitivity (asthma, rhinitis, angioedema, urticaria) to other NSAIDs including aspirin; severe heart failure; GI, cerebrovascular or other bleeding disorders; history of NSAID-related GI bleeding/perforation; active or recurrent peptic ulcer; severe hepatic impairment; severe renal impairment (serum creatinine >700 µmol/L); third trimester of pregnancy.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

تحذيرات واحتياطاتWarnings & precautions

Use with careful risk-benefit assessment in mild to moderate renal impairment, coagulation disorders, hepatic impairment and in the elderly; avoid combination with other NSAIDs including COX-2 inhibitors; use the lowest effective dose for the shortest duration.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA), Ireland

Use with careful risk-benefit assessment in mild to moderate renal impairment, coagulation disorders, hepatic impairment and in the elderly; avoid combination with other NSAIDs including COX-2 inhibitors; use the lowest effective dose for the shortest duration.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

الحمل والرضاعةPregnancy & breastfeeding

Contraindicated in the third trimester; should not be used in the first and second trimesters or during delivery because no clinical data on exposed pregnancies are available.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA), Ireland
No human data; lornoxicam is excreted in rat milk in relatively high concentrations, so it should not be used in breastfeeding women.نشرة دولية لنفس التركيبة · Health Products Regulatory Authority (HPRA), Ireland

Contraindicated in the third trimester; should not be used in the first and second trimesters or during delivery because no clinical data on exposed pregnancies are available.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland
No human data; lornoxicam is excreted in rat milk in relatively high concentrations, so it should not be used in breastfeeding women.International label, same formulation · Health Products Regulatory Authority (HPRA), Ireland

بننشر كل يوم أسعار أدوية اتغيرت والبدائل الأرخص

نفس المادة الفعالة والتركيز. اسأل الصيدلي قبل الاستبدال.

مثائل Xefo 8 mg vial i.m./i.v. بنفس المادة الفعالة والتركيز، مرتبة من الأرخص
الدواء	السعر	الفرق عن الأصلي
روكسيكام 8مجم للحقن عضل وريد فيالRheuxicam 8mg pd for i.m. / i.v. inj. vialChemipharm · 8 mgالأرخص	السعر26ج.م26ج.م للوحدة	الفرق عن الأصليأغلى 7.5ج.م (40.5%)

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.